bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary figure S4 from BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Authors: Luk Iris Sze Ue , Shrestha Raunak , Xue Hui , Wang Yuwei , Zhang Fang , Lin Dong , Haegert Anne , Wu Rebecca , Dong Xin , Collins Colin C. , Zoubeidi Amina , Gleave Martin E. , Gout Peter W. , Wang Yuzhuo
Published: April 2023

Serum PSA data of individual mice before and after treatment with ASO
Supplementary figure S3 from BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Authors: Luk Iris Sze Ue , Shrestha Raunak , Xue Hui , Wang Yuwei , Zhang Fang , Lin Dong , Haegert Anne , Wu Rebecca , Dong Xin , Collins Colin C. , Zoubeidi Amina , Gleave Martin E. , Gout Peter W. , Wang Yuzhuo
Published: April 2023

MTS Proliferation assay of MR49F cells treated with siControl or siXIAP at 20 nM. Results presented as growth rate relative to Mock at 96-hour after transfection
Supplementary figure S2 from BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Authors: Luk Iris Sze Ue , Shrestha Raunak , Xue Hui , Wang Yuwei , Zhang Fang , Lin Dong , Haegert Anne , Wu Rebecca , Dong Xin , Collins Colin C. , Zoubeidi Amina , Gleave Martin E. , Gout Peter W. , Wang Yuzhuo
Published: April 2023

MTS proliferation assay of MR42D ENZ-resistant CRPC cells treated with ASO-6w2
Table S1 from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Authors: Garsed Dale W. , Alsop Kathryn , Fereday Sian , Emmanuel Catherine , Kennedy Catherine J. , Etemadmoghadam Dariush , Gao Bo , Gebski Val , Garès Valérie , Christie Elizabeth L. , Wouters Maartje C.A. , Milne Katy , George Joshy , Patch Ann-Marie , Li Jason , Arnau Gisela Mir , Semple Timothy , Gadipally Sreeja R. , Chiew Yoke-Eng , Hendley Joy , Mikeska Thomas , Zapparoli Giada V. , Amarasinghe Kaushalya , Grimmond Sean M. , Pearson John V. , Waddell Nicola , Hung Jillian , Stewart Colin J.R. , Sharma Raghwa , Allan Prue E. , Rambau Peter F. , McNally Orla , Mileshkin Linda , Hamilton Anne , Ananda Sumitra , Grossi Marisa , Cohen Paul A. , Leung Yee C. , Rome Robert M. , Beale Philip , Blomfield Penny , Friedlander Michael , Brand Alison , Dobrovic Alexander , Köbel Martin , Harnett Paul , Nelson Brad H. , Bowtell David D. L. , deFazio Anna
Published: April 2023

Histotype classification
Supplementary figure S1 from BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Authors: Luk Iris Sze Ue , Shrestha Raunak , Xue Hui , Wang Yuwei , Zhang Fang , Lin Dong , Haegert Anne , Wu Rebecca , Dong Xin , Collins Colin C. , Zoubeidi Amina , Gleave Martin E. , Gout Peter W. , Wang Yuzhuo
Published: April 2023

BIRC6 mRNA levels in MR49F cells treated with ASO-6w2
Supplementary Table S3 from BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
Authors: Luk Iris Sze Ue , Shrestha Raunak , Xue Hui , Wang Yuwei , Zhang Fang , Lin Dong , Haegert Anne , Wu Rebecca , Dong Xin , Collins Colin C. , Zoubeidi Amina , Gleave Martin E. , Gout Peter W. , Wang Yuzhuo
Published: April 2023

Gene expression changes in matrisome genesets associated with ASO-6w2 treatment of LTL-313BR xenografts
Supplemental data from Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
Authors: Yang Zhe , Yang Nong , Ou Qiuxiang , Xiang Yi , Jiang Tao , Wu Xue , Bao Hua , Tong Xiaoling , Wang Xiaonan , Shao Yang W. , Liu Yunpeng , Wang Yan , Zhou Caicun
Published: April 2023

Supplemental data
Supplementary Data from Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma
Authors: Andrews April , Warner Kristy , Rodriguez-Ramirez Christie , Pearson Alexander T. , Nör Felipe , Zhang Zhaocheng , Kerk Samuel , Kulkarni Aditi , Helman Joseph I. , Brenner J. Chad , Wicha Max S. , Wang Shaomeng , Nör Jacques E.
Published: April 2023

Supplementary Methods Supplementary Figure Legends 2 Supplementary Figures
Sup File 1 from Lymph Node Metastases in Colon Cancer Are Polyclonal
Authors: Ulintz Peter J. , Greenson Joel K. , Wu Rong , Fearon Eric R. , Hardiman Karin M.
Published: April 2023

Sup File 1 PyClone Similarity Matrix Plots
Supplementary Table from Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer
Authors: Muliaditan Tamara , Opzoomer James W. , Caron Jonathan , Okesola Mary , Kosti Paris , Lall Sharanpreet , Van Hemelrijck Mieke , Dazzi Francesco , Tutt Andrew , Grigoriadis Anita , Gillett Cheryl E. , Madden Stephen F. , Burchell Joy M. , Kordasti Shahram , Diebold Sandra S. , Spicer James F. , Arnold James N.
Published: April 2023

Cell type specific markers and genes
Sup Fig 2 from Lymph Node Metastases in Colon Cancer Are Polyclonal
Authors: Ulintz Peter J. , Greenson Joel K. , Wu Rong , Fearon Eric R. , Hardiman Karin M.
Published: April 2023

TAPS chromosomal plots
Supplementary Table from Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer
Authors: Muliaditan Tamara , Opzoomer James W. , Caron Jonathan , Okesola Mary , Kosti Paris , Lall Sharanpreet , Van Hemelrijck Mieke , Dazzi Francesco , Tutt Andrew , Grigoriadis Anita , Gillett Cheryl E. , Madden Stephen F. , Burchell Joy M. , Kordasti Shahram , Diebold Sandra S. , Spicer James F. , Arnold James N.
Published: April 2023

Patient demographic of low and high quartiles of HMOX1 expressing tumors from the METABRIC dataset
Supplementary table S4 from Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
Authors: van Kessel Kim E.M. , van der Keur Kirstin A. , Dyrskjøt Lars , Algaba Ferran , Welvaart Naeromy Y.C. , Beukers Willemien , Segersten Ulrika , Keck Bastian , Maurer Tobias , Simic Tatjana , Horstmann Marcus , Grimm Marc-Oliver , Hermann Gregers G. , Mogensen Karin , Hartmann Arndt , Harving Niels , Petersen Astrid C. , Jensen Jørgen B. , Junker Kerstin , Boormans Joost L. , Real Francisco X. , Malats Núria , Malmström Per-Uno , Ørntoft Torben F. , Zwarthoff Ellen C.
Published: April 2023

Supplementary Table S4. Number of patients progressing to MIBC and person-time per risk group. Suggested risk groups are based on a combination of GATA2 methylation and FGFR3 mutation status for EAU high risk tumors.
Supplementary figure S8 from Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
Authors: van Kessel Kim E.M. , van der Keur Kirstin A. , Dyrskjøt Lars , Algaba Ferran , Welvaart Naeromy Y.C. , Beukers Willemien , Segersten Ulrika , Keck Bastian , Maurer Tobias , Simic Tatjana , Horstmann Marcus , Grimm Marc-Oliver , Hermann Gregers G. , Mogensen Karin , Hartmann Arndt , Harving Niels , Petersen Astrid C. , Jensen Jørgen B. , Junker Kerstin , Boormans Joost L. , Real Francisco X. , Malats Núria , Malmström Per-Uno , Ørntoft Torben F. , Zwarthoff Ellen C.
Published: April 2023

Supplementary figure S8. Progression-free survival curve in patients with EAU high risk tumors of a combination of FGFR3 and GATA2 status. Blue: good status (hypomethylated GATA2 and mutated FGFR3), green; moderate status (either hypermethylated GATA2 and mutated FGFR3 or hypomethylated GATA2 and wild type FGFR3) or red: poor status (hypermethylated GATA2 and wild type FGFR3) compared to a progression free survival curse in all EAU high risk patients. Progressive disease is defined as progression to stage T2 or higher stage disease.
Legends for Supplemental Figures from Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis
Authors: Aushev Vasily N. , Lee Eunjee , Zhu Jun , Gopalakrishnan Kalpana , Li Qian , Teitelbaum Susan L. , Wetmur James , Degli Esposti Davide , Hernandez-Vargas Hector , Herceg Zdenko , Parada Humberto , Santella Regina M. , Gammon Marilie D. , Chen Jia
Published: April 2023

Legends for Supplemental Figures
Supplementary figure S5 from Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
Authors: van Kessel Kim E.M. , van der Keur Kirstin A. , Dyrskjøt Lars , Algaba Ferran , Welvaart Naeromy Y.C. , Beukers Willemien , Segersten Ulrika , Keck Bastian , Maurer Tobias , Simic Tatjana , Horstmann Marcus , Grimm Marc-Oliver , Hermann Gregers G. , Mogensen Karin , Hartmann Arndt , Harving Niels , Petersen Astrid C. , Jensen Jørgen B. , Junker Kerstin , Boormans Joost L. , Real Francisco X. , Malats Núria , Malmström Per-Uno , Ørntoft Torben F. , Zwarthoff Ellen C.
Published: April 2023

Supplementary figure S5. Progression-free survival curves in all patients for (A) EAU risk category, (B) FGFR3, (C) GATA2 and (D) TBX3. Progressive disease is defined as progression to stage T2 or higher stage disease. P-values (log-rank test) are indicated in each figure.
Figure S7 from Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis
Authors: Aushev Vasily N. , Lee Eunjee , Zhu Jun , Gopalakrishnan Kalpana , Li Qian , Teitelbaum Susan L. , Wetmur James , Degli Esposti Davide , Hernandez-Vargas Hector , Herceg Zdenko , Parada Humberto , Santella Regina M. , Gammon Marilie D. , Chen Jia
Published: April 2023

Fig. S7. Validation of the associations found in the current study, by the METABRIC dataset, keeping the cutoff selected by LIBCSP dataset. Horizontal axis displays hazards ratio for given gene in the LIBCSP dataset, vertical axis shows HR for METABRIC dataset. Size of the dot indicates p-value for METABRIC dataset. Pink colors marks the genes of PAM50 panel.
Figure S4 from Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis
Authors: Aushev Vasily N. , Lee Eunjee , Zhu Jun , Gopalakrishnan Kalpana , Li Qian , Teitelbaum Susan L. , Wetmur James , Degli Esposti Davide , Hernandez-Vargas Hector , Herceg Zdenko , Parada Humberto , Santella Regina M. , Gammon Marilie D. , Chen Jia
Published: April 2023

Fig. S4. Principal component analysis of gene expression levels.
Table S6 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Authors: Sandulache Vlad C. , Michikawa Chieko , Kataria Pranav , Gleber-Netto Frederico O. , Bell Diana , Trivedi Sanchit , Rao Xiayu , Wang Jing , Zhao Mei , Jasser Samar , Myers Jeffrey N. , Pickering Curtis R.
Published: April 2023

Table S6 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Figure S2 from Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis
Authors: Aushev Vasily N. , Lee Eunjee , Zhu Jun , Gopalakrishnan Kalpana , Li Qian , Teitelbaum Susan L. , Wetmur James , Degli Esposti Davide , Hernandez-Vargas Hector , Herceg Zdenko , Parada Humberto , Santella Regina M. , Gammon Marilie D. , Chen Jia
Published: April 2023

Fig. S2. Function of false-positives (red line), false-negatives (green line) and sum of false-positives and false-negatives (blue line), depending on the cut-off value of gene expression levels. Horizontal line indicates the cut-off chosen as giving the minimal sum of false-positives and false-negatives.
Table S4 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Authors: Sandulache Vlad C. , Michikawa Chieko , Kataria Pranav , Gleber-Netto Frederico O. , Bell Diana , Trivedi Sanchit , Rao Xiayu , Wang Jing , Zhao Mei , Jasser Samar , Myers Jeffrey N. , Pickering Curtis R.
Published: April 2023

Table S4 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Table S3 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Authors: Sandulache Vlad C. , Michikawa Chieko , Kataria Pranav , Gleber-Netto Frederico O. , Bell Diana , Trivedi Sanchit , Rao Xiayu , Wang Jing , Zhao Mei , Jasser Samar , Myers Jeffrey N. , Pickering Curtis R.
Published: April 2023

Supp Table 3
Table S2 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Authors: Sandulache Vlad C. , Michikawa Chieko , Kataria Pranav , Gleber-Netto Frederico O. , Bell Diana , Trivedi Sanchit , Rao Xiayu , Wang Jing , Zhao Mei , Jasser Samar , Myers Jeffrey N. , Pickering Curtis R.
Published: April 2023

Table S2 from High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Conflict Interest disclosure from Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response
Authors: Zhang Jingli , Khanna Swati , Jiang Qun , Alewine Christine , Miettinen Markku , Pastan Ira , Hassan Raffit
Published: April 2023

Conflict of Interest Form
Figure S6 from Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Chang Matthew T. , Penson Alexander , Desai Neil B. , Socci Nicholas D. , Shen Ronglai , Seshan Venkatraman E. , Kundra Ritika , Abeshouse Adam , Viale Agnes , Cha Eugene K. , Hao Xueli , Reuter Victor E. , Rudin Charles M. , Bochner Bernard H. , Rosenberg Jonathan E. , Bajorin Dean F. , Schultz Nikolaus , Berger Michael F. , Iyer Gopa , Solit David B. , Al-Ahmadie Hikmat A. , Taylor Barry S.
Published: April 2023

Supplementary Figure 6: Mixed histology tumors.
Figure S5 from Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Chang Matthew T. , Penson Alexander , Desai Neil B. , Socci Nicholas D. , Shen Ronglai , Seshan Venkatraman E. , Kundra Ritika , Abeshouse Adam , Viale Agnes , Cha Eugene K. , Hao Xueli , Reuter Victor E. , Rudin Charles M. , Bochner Bernard H. , Rosenberg Jonathan E. , Bajorin Dean F. , Schultz Nikolaus , Berger Michael F. , Iyer Gopa , Solit David B. , Al-Ahmadie Hikmat A. , Taylor Barry S.
Published: April 2023

Supplementary Figure 5: Schematic of TP53 alteration classes.
Supplementary Figure 1 from Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study
Authors: Pietrantonio Filippo , Fucà Giovanni , Morano Federica , Gloghini Annunziata , Corso Simona , Aprile Giuseppe , Perrone Federica , De Vita Ferdinando , Tamborini Elena , Tomasello Gianluca , Gualeni Ambra Vittoria , Ongaro Elena , Busico Adele , Giommoni Elisa , Volpi Chiara Costanza , Laterza Maria Maddalena , Corallo Salvatore , Prisciandaro Michele , Antista Maria , Pellegrinelli Alessandro , Castagnoli Lorenzo , Pupa Serenella M. , Pruneri Giancarlo , de Braud Filippo , Giordano Silvia , Cremolini Chiara , Di Bartolomeo Maria
Published: April 2023

Definition of trastuzumab resistant (A) and trastuzumab sensitive (B) patients according to combined assessment of RECIST response and time to progression to trastuzumab plus cisplatin/fluoropyrimidine induction treatment given for up to 6 cycles and followed by maintenance treatment with trastuzumab alone until disease progression.
Figure S4 from Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Chang Matthew T. , Penson Alexander , Desai Neil B. , Socci Nicholas D. , Shen Ronglai , Seshan Venkatraman E. , Kundra Ritika , Abeshouse Adam , Viale Agnes , Cha Eugene K. , Hao Xueli , Reuter Victor E. , Rudin Charles M. , Bochner Bernard H. , Rosenberg Jonathan E. , Bajorin Dean F. , Schultz Nikolaus , Berger Michael F. , Iyer Gopa , Solit David B. , Al-Ahmadie Hikmat A. , Taylor Barry S.
Published: April 2023

Supplementary Figure 4: Complex E2F3 amplicon.
Figure S3 from Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Chang Matthew T. , Penson Alexander , Desai Neil B. , Socci Nicholas D. , Shen Ronglai , Seshan Venkatraman E. , Kundra Ritika , Abeshouse Adam , Viale Agnes , Cha Eugene K. , Hao Xueli , Reuter Victor E. , Rudin Charles M. , Bochner Bernard H. , Rosenberg Jonathan E. , Bajorin Dean F. , Schultz Nikolaus , Berger Michael F. , Iyer Gopa , Solit David B. , Al-Ahmadie Hikmat A. , Taylor Barry S.
Published: April 2023

Supplementary Figure 3: DNA copy number alterations in SCCB.
Figure S1 from Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Chang Matthew T. , Penson Alexander , Desai Neil B. , Socci Nicholas D. , Shen Ronglai , Seshan Venkatraman E. , Kundra Ritika , Abeshouse Adam , Viale Agnes , Cha Eugene K. , Hao Xueli , Reuter Victor E. , Rudin Charles M. , Bochner Bernard H. , Rosenberg Jonathan E. , Bajorin Dean F. , Schultz Nikolaus , Berger Michael F. , Iyer Gopa , Solit David B. , Al-Ahmadie Hikmat A. , Taylor Barry S.
Published: April 2023

Supplementary Figure 1: RB-wildtype SCCBs are RB-null.
Supplemental Figure S5 from MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies
Authors: Liu Liqin , Lam Chia-Ying K. , Long Vatana , Widjaja Lusiana , Yang Yinhua , Li Hua , Jin Linda , Burke Steve , Gorlatov Sergey , Brown Jennifer , Alderson Ralph , Lewis Margaret D. , Nordstrom Jeffrey L. , Koenig Scott , Moore Paul A. , Johnson Syd , Bonvini Ezio
Published: April 2023

MGD011 inhibited tumor dissemination and improved survival in a disseminated leukemia/lymphoma model in humanized mice
Supplemental Figure S1 from MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies
Authors: Liu Liqin , Lam Chia-Ying K. , Long Vatana , Widjaja Lusiana , Yang Yinhua , Li Hua , Jin Linda , Burke Steve , Gorlatov Sergey , Brown Jennifer , Alderson Ralph , Lewis Margaret D. , Nordstrom Jeffrey L. , Koenig Scott , Moore Paul A. , Johnson Syd , Bonvini Ezio
Published: April 2023

Molecular weight, purity and SPR analysis of MGD011
Table S2 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Authors: Deel Michael D. , Slemmons Katherine K. , Hinson Ashley R. , Genadry Katia C. , Burgess Breanne A. , Crose Lisa E.S. , Kuprasertkul Nina , Oristian Kristianne M. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

Details of Human Tissue Microarray.
Table S1 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Authors: Deel Michael D. , Slemmons Katherine K. , Hinson Ashley R. , Genadry Katia C. , Burgess Breanne A. , Crose Lisa E.S. , Kuprasertkul Nina , Oristian Kristianne M. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PCR Primers for quantitative qRT-PCR.
Supplementary Table 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

Patient and Control Characteristics
Supplementary Figure 7 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

T cell counts per gram of tumor across tumor models
Supplementary Figure 6 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

T cell exhaustion in brain metastases models
Supplementary Figure 5 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

Immune checkpoint and cytokine expression on human GBM CD4+ TIL
Figure S3 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Authors: Deel Michael D. , Slemmons Katherine K. , Hinson Ashley R. , Genadry Katia C. , Burgess Breanne A. , Crose Lisa E.S. , Kuprasertkul Nina , Oristian Kristianne M. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

TAZ is also highly abundant in human eRMS cell lines and tumors. TAZ expression does not correlate with YAP expression in human RMS tumors.
Supplementary Figure 2 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

Memory phenotype of human GBM TIL
Figure S2 from The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Authors: Deel Michael D. , Slemmons Katherine K. , Hinson Ashley R. , Genadry Katia C. , Burgess Breanne A. , Crose Lisa E.S. , Kuprasertkul Nina , Oristian Kristianne M. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

Standards used for TAZ IHC scoring in murine xenografts.
Supplementary Figure 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Authors: Woroniecka Karolina , Chongsathidkiet Pakawat , Rhodin Kristen , Kemeny Hanna , Dechant Cosette , Farber S. Harrison , Elsamadicy Aladine A. , Cui Xiuyu , Koyama Shohei , Jackson Christina , Hansen Landon J. , Johanns Tanner M. , Sanchez-Perez Luis , Chandramohan Vidyalakshmi , Yu Yen-Rei Andrea , Bigner Darell D. , Giles Amber , Healy Patrick , Dranoff Glenn , Weinhold Kent J. , Dunn Gavin P. , Fecci Peter E.
Published: April 2023

Gating strategy for tumor infiltrating lymphocytes
Supplementary Movie S3 from Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer
Authors: Chen Chun-Han , Changou Chun A. , Hsieh Tsung-Han , Lee Yu-Ching , Chu Cheng-Ying , Hsu Kai-Cheng , Wang Hao-Ching , Lin Yu-Chen , Lo Yan-Ni , Liu Yun-Ru , Liou Jing-Ping , Yen Yun
Published: April 2023

Effect of MPT0L145 on endosomal functions.
Supplementary Movie S1 from Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer
Authors: Chen Chun-Han , Changou Chun A. , Hsieh Tsung-Han , Lee Yu-Ching , Chu Cheng-Ying , Hsu Kai-Cheng , Wang Hao-Ching , Lin Yu-Chen , Lo Yan-Ni , Liu Yun-Ru , Liou Jing-Ping , Yen Yun
Published: April 2023

Effect of MPT0L145 on autophagosome formation.
Supplementary Table 2 from Vitamin D–Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription
Authors: Huang Yu-Fang , Wu Yi-Hui , Cheng Wen-Fang , Peng Shu-Ling , Shen Wan-Lin , Chou Cheng-Yang
Published: April 2023

Univariate and multivariate analysis of prognostic factors and pretreatment DBP expressions at diagnosis in epithelial ovarian cancers (n = 225) in NCKUH and NTUH
Supplementary Table 1 from Vitamin D–Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription
Authors: Huang Yu-Fang , Wu Yi-Hui , Cheng Wen-Fang , Peng Shu-Ling , Shen Wan-Lin , Chou Cheng-Yang
Published: April 2023

Ascitic and serum DBP and clinicopathological factors in epithelial ovarian cancers (n = 225) in NCKUH and NTUH
Supplementary Tables from Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
Authors: Ward Elspeth , Varešlija Damir , Charmsaz Sara , Fagan Ailis , Browne Alacoque L. , Cosgrove Nicola , Cocchiglia Sinéad , Purcell Siobhan P. , Hudson Lance , Das Sudipto , O'Connor Darran , O'Halloran Philip J. , Sims Andrew H. , Hill Arnold D. , Young Leonie S.
Published: April 2023

Table S1: 736 genes downregulated in LY2 shNT (Ensemble ID)
Table S1 from Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy
Authors: Ribba Benjamin , Boetsch Christophe , Nayak Tapan , Grimm Hans Peter , Charo Jehad , Evers Stefan , Klein Christian , Tessier Jean , Charoin Jean Eric , Phipps Alex , Pisa Pavel , Teichgräber Volker
Published: April 2023

Supplementary Table S1: Characteristics in terms of CEA status, dose received and cancer indication of the 14 patients from the functional imaging study.
Supplementary Figure S3 from Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status
Authors: Uckermann Ortrud , Juratli Tareq A. , Galli Roberta , Conde Marina , Wiedemuth Ralf , Krex Dietmar , Geiger Kathrin , Temme Achim , Schackert Gabriele , Koch Edmund , Steiner Gerald , Kirsch Matthias
Published: April 2023

Cell density in IDH1-wt and IDH1-mut human glioma samples.
Supplemental legend from Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy
Authors: Ribba Benjamin , Boetsch Christophe , Nayak Tapan , Grimm Hans Peter , Charo Jehad , Evers Stefan , Klein Christian , Tessier Jean , Charoin Jean Eric , Phipps Alex , Pisa Pavel , Teichgräber Volker
Published: April 2023

Supplemental legend
Supplementary Figure S2 from Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status
Authors: Uckermann Ortrud , Juratli Tareq A. , Galli Roberta , Conde Marina , Wiedemuth Ralf , Krex Dietmar , Geiger Kathrin , Temme Achim , Schackert Gabriele , Koch Edmund , Steiner Gerald , Kirsch Matthias
Published: April 2023

FT-IR imaging.
Supp Figure S7 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Authors: Zhu Shoumin , Chen Zheng , Wang Lihong , Peng Dunfa , Belkhiri Abbes , Lockhart A. Craig , El-Rifai Wael
Published: April 2023

Supp Figure S7
Supp Figure S6 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Authors: Zhu Shoumin , Chen Zheng , Wang Lihong , Peng Dunfa , Belkhiri Abbes , Lockhart A. Craig , El-Rifai Wael
Published: April 2023

Supp Figure S6
Supp Figure S4 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Authors: Zhu Shoumin , Chen Zheng , Wang Lihong , Peng Dunfa , Belkhiri Abbes , Lockhart A. Craig , El-Rifai Wael
Published: April 2023

Supp Figure S4
Supp Figure S10 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Authors: Zhu Shoumin , Chen Zheng , Wang Lihong , Peng Dunfa , Belkhiri Abbes , Lockhart A. Craig , El-Rifai Wael
Published: April 2023

Supp Figure S10
Supp Figure S1 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
Authors: Zhu Shoumin , Chen Zheng , Wang Lihong , Peng Dunfa , Belkhiri Abbes , Lockhart A. Craig , El-Rifai Wael
Published: April 2023

Supp Figure S1
Supplementary Table S2 from Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
Authors: Mason Nicola J. , Gnanandarajah Josephine S. , Engiles Julie B. , Gray Falon , Laughlin Danielle , Gaurnier-Hausser Anita , Wallecha Anu , Huebner Margie , Paterson Yvonne
Published: April 2023

Signalment and primary tumor characteristics of dogs with pre-existing metastatic disease treated on a compassionate care basis.
Supplementary Table S1 from Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
Authors: Mason Nicola J. , Gnanandarajah Josephine S. , Engiles Julie B. , Gray Falon , Laughlin Danielle , Gaurnier-Hausser Anita , Wallecha Anu , Huebner Margie , Paterson Yvonne
Published: April 2023

Signalment and primary tumor characteristics of enrolled dogs that received ADXS31-164.
Table S1-S12 from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
Authors: Asiedu Michael K. , Thomas Charles F. , Dong Jie , Schulte Sandra C. , Khadka Prasidda , Sun Zhifu , Kosari Farhad , Jen Jin , Molina Julian , Vasmatzis George , Kuang Ray , Aubry Marie Christine , Yang Ping , Wigle Dennis A.
Published: April 2023

Table S1: Clinicopathologic features Table S2: Statistical analysis of correlation between number of mutations with sevaral clinical characteristics Table S3: List of copy number variations in different types of pulmonary neuroendocrine tumors as reported by different studies. Lung typical carcinoid (TC), Lung atypical carcinoid Table S4: Table S2. List of genes differentially expressed genes in regions of corresponding copy number variation (red signifies amplification and blue represent deletion) Table S5: Functional analysis using the DAVID functional annotation database Table S6: A table of significantly mutated genes determine by MutSigCV analysis. Table S7: Ingenuity pathway analysis of Significant mutated gene with q<0.5 Table S8: MutSig analysis of chromatin remodeling genes Table S9: A listed of validated cancer causal genes by ingenuity variant analysis and Oncotator annotation and filtering Table S10. Common CNV genes identified by both SNP array and WGS Table S11: Canonical pathways identified by Ingenuity Pathway analysis of Fernandez-Cuesta et al RNASeq data Table S12: List of chromatin remodelling genes with damaging and functional variants by analysis pipeline
Supplementary Fig S1 from Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
Authors: Mason Nicola J. , Gnanandarajah Josephine S. , Engiles Julie B. , Gray Falon , Laughlin Danielle , Gaurnier-Hausser Anita , Wallecha Anu , Huebner Margie , Paterson Yvonne
Published: April 2023

Effects of ADXS31-164 on hematological parameters at 24 hours post infusion.
Fig S6 from Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
Authors: Takagi Satoshi , Tsukamoto Shokichi , Park Jihye , Johnson Kelly E. , Kawano Yawara , Moschetta Michele , Liu Chia-Jen , Mishima Yuji , Kokubun Katsutoshi , Manier Salomon , Salem Karma Z. , Huynh Daisy , Sacco Antonio , Forward Jodi , Roccaro Aldo M. , Battinelli Elisabeth M. , Ghobrial Irene M.
Published: April 2023

Co-culture with platelets increases the IL-1β mRNA levels in MM cells.
Supplementary Data-Clean Version from Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling
Authors: Tian Yanhua , Wang Zhijie , Liu Xiaohui , Duan Jianchun , Feng Guoshuang , Yin Yuxin , Gu Jin , Chen Zhaoli , Gao Shugeng , Bai Hua , Wan Rui , Jiang Jun , Liu Jia , Zhang Cong , Wang Di , Han Jiefei , Zhang Xue , Cai Liangliang , He Jie , Wang Jie
Published: April 2023

Fig. S1. Principal component analysis (PCA) of QC and experimental samples. Fig S2. Determination of chemical structures of metabolites in serum extract by tandem mass spectrometry. Fig. S3. Relative abundance of the 11 metabolites in the pemetrexed monotherapy set. Fig. S4. 5-fold cross validation result. Fig. S5. ROC analysis of the discovery set. Fig. S6. Relative abundance of the 11 metabolites in the validation set. Fig. S7. ROC analysis of the validation set. Fig. S8. Parameter settings for LC-MS/MS. Supplementary Table S1. Metabolites identified in the discovery set. Supplementary Table S2. The likelihood score in different models with various number of variables.
Supplemental Fig 2 from Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Authors: Tang Chad , Welsh James W. , de Groot Patricia , Massarelli Erminia , Chang Joe Y. , Hess Kenneth R. , Basu Sreyashi , Curran Michael A. , Cabanillas Maria E. , Subbiah Vivek , Fu Siqing , Tsimberidou Apostolia M. , Karp Daniel , Gomez Daniel R. , Diab Adi , Komaki Ritsuko , Heymach John V. , Sharma Padmanee , Naing Aung , Hong David S.
Published: April 2023

Treg Expression
Supplementary Table S1. from Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Authors: Rossi Giovanna , Mu Zhaomei , Rademaker Alfred W. , Austin Laura K. , Strickland Kimberly S. , Costa Ricardo Lima Barros , Nagy Rebecca J. , Zagonel Vittorina , Taxter Timothy J. , Behdad Amir , Wehbe Firas H. , Platanias Leonidas C. , Gradishar William J. , Cristofanilli Massimo
Published: April 2023

Guardant360TM: 70-Gene Panel.
Tables S2-S5 from Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer
Authors: Haynes Jennifer , McKee Trevor D. , Haller Andrew , Wang Yadong , Leung Cherry , Gendoo Deena M.A. , Lima-Fernandes Evelyne , Kreso Antonija , Wolman Robin , Szentgyorgyi Eva , Vines Douglass C. , Haibe-Kains Benjamin , Wouters Bradly G. , Metser Ur , Jaffray David A. , Smith Myles , O'Brien Catherine A.
Published: April 2023

Supplementary Table S2. Sphere-initiating frequency in hypoxia as measured by LDA in vitro, related to Figure 1C. Supplementary Table S3. C-IC frequency following hypoxia as measured by LDA in vivo, related to Figure 1D. Supplementary Table S4. C-IC frequency following 5-FU + Evo as measured by LDA in vivo, related to Figure 5C. Supplementary Table S5. C-IC frequency following CRT + Evo as measured by LDA in vivo, related to Figure 5D.
Table S1 from Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer
Authors: Haynes Jennifer , McKee Trevor D. , Haller Andrew , Wang Yadong , Leung Cherry , Gendoo Deena M.A. , Lima-Fernandes Evelyne , Kreso Antonija , Wolman Robin , Szentgyorgyi Eva , Vines Douglass C. , Haibe-Kains Benjamin , Wouters Bradly G. , Metser Ur , Jaffray David A. , Smith Myles , O'Brien Catherine A.
Published: April 2023

Supplementary Table S1. Summary of colorectal cancer patient samples used in this study. The tissue site from which samples originated or were collected, disease stage, and main driver mutations are listed.
Supplementary Table 2 from Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
Authors: Canale Matteo , Petracci Elisabetta , Delmonte Angelo , Chiadini Elisa , Dazzi Claudio , Papi Maximilian , Capelli Laura , Casanova Claudia , De Luigi Nicoletta , Mariotti Marita , Gamboni Alessandro , Chiari Rita , Bennati Chiara , Calistri Daniele , Ludovini Vienna , Crinò Lucio , Amadori Dino , Ulivi Paola
Published: April 2023

Relation of TP53 mutations and clinical characteristics of patients
Supplementary Table 1 from Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
Authors: Canale Matteo , Petracci Elisabetta , Delmonte Angelo , Chiadini Elisa , Dazzi Claudio , Papi Maximilian , Capelli Laura , Casanova Claudia , De Luigi Nicoletta , Mariotti Marita , Gamboni Alessandro , Chiari Rita , Bennati Chiara , Calistri Daniele , Ludovini Vienna , Crinò Lucio , Amadori Dino , Ulivi Paola
Published: April 2023

Distribution of disruptive and non-disruptive mutations in the different types of TP53 mutations
supplemental data 2 from The RARS–MAD1L1 Fusion Gene Induces Cancer Stem Cell–like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
Authors: Zhong Qian , Liu Zhi-Hua , Lin Zhi-Rui , Hu Ze-Dong , Yuan Li , Liu Yan-min , Zhou Ai-Jun , Xu Li-Hua , Hu Li-Juan , Wang Zi-Feng , Guan Xin-Yuan , Hao Jia-Jie , Lui Vivian W.Y. , Guo Ling , Mai Hai-Qiang , Chen Ming-Yuan , Han Fei , Xia Yun-Fei , Grandis Jennifer R. , Zhang Xing , Zeng Mu-Sheng
Published: April 2023

RARS-MAD1L1 sequence
supplemental Table 1 from The RARS–MAD1L1 Fusion Gene Induces Cancer Stem Cell–like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
Authors: Zhong Qian , Liu Zhi-Hua , Lin Zhi-Rui , Hu Ze-Dong , Yuan Li , Liu Yan-min , Zhou Ai-Jun , Xu Li-Hua , Hu Li-Juan , Wang Zi-Feng , Guan Xin-Yuan , Hao Jia-Jie , Lui Vivian W.Y. , Guo Ling , Mai Hai-Qiang , Chen Ming-Yuan , Han Fei , Xia Yun-Fei , Grandis Jennifer R. , Zhang Xing , Zeng Mu-Sheng
Published: April 2023

charateritics of 84 HNSCC patients
Supplementary Table 1 from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy
Authors: Bolyard Chelsea , Meisen W. Hans , Banasavadi-Siddegowda Yeshavanth , Hardcastle Jayson , Yoo Ji Young , Wohleb Eric S. , Wojton Jeffrey , Yu Jun-Ge , Dubin Samuel , Khosla Maninder , Xu Bo , Smith Jonathan , Alvarez-Breckenridge Christopher , Pow-anpongkul Pete , Pichiorri Flavia , Zhang Jianying , Old Matthew , Zhu Dan , Van Meir Erwin G. , Godbout Jonathan P. , Caligiuri Michael A. , Yu Jianhua , Kaur Balveen
Published: April 2023

List of genes significantly up-regulated (>1.5 fold) in macrophages upon culture with glioma cells infected with RAMBO (R) or rHSVQ1 (Q) relative to uninfected (UI) cells.
Supplementary Information from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy
Authors: Bolyard Chelsea , Meisen W. Hans , Banasavadi-Siddegowda Yeshavanth , Hardcastle Jayson , Yoo Ji Young , Wohleb Eric S. , Wojton Jeffrey , Yu Jun-Ge , Dubin Samuel , Khosla Maninder , Xu Bo , Smith Jonathan , Alvarez-Breckenridge Christopher , Pow-anpongkul Pete , Pichiorri Flavia , Zhang Jianying , Old Matthew , Zhu Dan , Van Meir Erwin G. , Godbout Jonathan P. , Caligiuri Michael A. , Yu Jianhua , Kaur Balveen
Published: April 2023

Supplementary Methods, Figure Legends and References.
Video S1 from Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo
Authors: Laszlo Viktoria , Valko Zsuzsanna , Kovacs Ildiko , Ozsvar Judit , Hoda Mir Alireza , Klikovits Thomas , Lakatos Dora , Czirok Andras , Garay Tamas , Stiglbauer Alexander , Helbich Thomas H. , Gröger Marion , Tovari Jozsef , Klepetko Walter , Pirker Christine , Grusch Michael , Berger Walter , Hilberg Frank , Hegedus Balazs , Dome Balazs
Published: April 2023

The effect of nintedanib treatment on the migratory activity of the SPC212 cells
Supplementary Table S2 from Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo
Authors: Laszlo Viktoria , Valko Zsuzsanna , Kovacs Ildiko , Ozsvar Judit , Hoda Mir Alireza , Klikovits Thomas , Lakatos Dora , Czirok Andras , Garay Tamas , Stiglbauer Alexander , Helbich Thomas H. , Gröger Marion , Tovari Jozsef , Klepetko Walter , Pirker Christine , Grusch Michael , Berger Walter , Hilberg Frank , Hegedus Balazs , Dome Balazs
Published: April 2023

Mutational status of tumor suppressor genes of MPM cell lines
Supplementary Table S1 from Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo
Authors: Laszlo Viktoria , Valko Zsuzsanna , Kovacs Ildiko , Ozsvar Judit , Hoda Mir Alireza , Klikovits Thomas , Lakatos Dora , Czirok Andras , Garay Tamas , Stiglbauer Alexander , Helbich Thomas H. , Gröger Marion , Tovari Jozsef , Klepetko Walter , Pirker Christine , Grusch Michael , Berger Walter , Hilberg Frank , Hegedus Balazs , Dome Balazs
Published: April 2023

Histological subtypes, drug sensitivitiy data and copy number changes of target RTKs in MPM cell lines
Figure S1-S5 from Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP
Authors: Piggott Luke , Silva Andreia , Robinson Timothy , Santiago-Gómez Angelica , Simões Bruno M. , Becker Michael , Fichtner Iduna , Andera Ladislav , Young Philippa , Morris Christine , Barrett-Lee Peter , Alchami Fouad , Piva Marco , Vivanco Maria dM. , Clarke Robert B. , Gee Julia , Clarkson Richard
Published: April 2023

Figure S1: Endocrine-resistant MCF-7 cells demonstrate sensitivity to TRAIL Figure S2: Endocrine-resistant CSCs demonstrate sensitivity to TRIAL. Figure S3: Primary-derived patient samples. Figure S4: Endocrine-resistant primary and PDX tumour cells are sensitive to TRAIL. Figure S5: Mechanism of endocrine-resistant tumour cell sensitivity to TRAIL.
Supplementary Materials & Methods from STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Authors: Maranto Cristina , Udhane Vindhya , Hoang David T. , Gu Lei , Alexeev Vitali , Malas Kareem , Cardenas Karmel , Brody Jonathan R. , Rodeck Ulrich , Bergom Carmen , Iczkowski Ken A. , Jacobsohn Ken , See William , Schmitt Sara M. , Nevalainen Marja T.
Published: April 2023

Supplementary Materials & Methods
Supplementary Table S1: Additional metastatic pancreatic adenocarcinoma trials from Current and Emerging Therapies in Metastatic Pancreatic Cancer
Authors: Manji Gulam Abbas , Olive Kenneth P. , Saenger Yvonne M. , Oberstein Paul
Published: April 2023

Supplementary Table S1: Additional PDAC trials
Supplementary Tables S1-S8 from FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
Authors: Hsu Chia-Ying , Chang Gee-Chen , Chen Yi-Ju , Hsu Yi-Chiung , Hsiao Yi-Jing , Su Kang-Yi , Chen Hsuan-Yu , Lin Chien-Yu , Chen Jin-Shing , Chen Yu-Ju , Hong Qi-Sheng , Ku Wen-Hui , Wu Chih-Ying , Ho Bing-Ching , Chiang Ching-Cheng , Yang Pan-Chyr , Yu Sung-Liang
Published: April 2023

show Table S1-S8
Supplementary figure S4 from Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population
Authors: Hart Christopher D. , Vignoli Alessia , Tenori Leonardo , Uy Gemma Leonora , Van To Ta , Adebamowo Clement , Hossain Syed Mozammel , Biganzoli Laura , Risi Emanuela , Love Richard R. , Luchinat Claudio , Di Leo Angelo
Published: April 2023

Illustration of the significant differences in metabolomic spectra between serum samples from current study and those from the MSKCC cohort used in a previous study. Differences due to location far overwhelm differences between EBC and MBC spectra, and preclude the RF risk score from predicting relapse. A. Clustering of CPMG spectra using first two components of supervised PCA-CA. Each dot represents an EBC patient and each triangle a MBC patients. In red are reported the samples collected for this study and in green the MSKCC samples. The confusion matrix and the accuracy of the discrimination between the samples of the two studies are also reported. B. Predictive ability of the RF risk score developed on the MSKCC data set in the current cohort, using ROC analysis. AUC and the confusion matrix are presented for the CPMG RF scores, calculated using the model built on the MSKCC samples, in the test set.
Supplementary figure S3 from Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population
Authors: Hart Christopher D. , Vignoli Alessia , Tenori Leonardo , Uy Gemma Leonora , Van To Ta , Adebamowo Clement , Hossain Syed Mozammel , Biganzoli Laura , Risi Emanuela , Love Richard R. , Luchinat Claudio , Di Leo Angelo
Published: April 2023

Clustering of serum metabolomic profiles using Random Forest classification to discriminate EBC patients according to different clinicopathological parameters. This illustrates the degree to which each parameter influences the spectra. A) Age of patients, divided into two groups using the median age as threshold (red dots - age < 43 years; blue dots - age {greater than or equal to} 43 years); B) HER2 positivity (red dots - HER2 positive; blue dots - HER2 negative); C) Size of the tumor (red dots - size {less than or equal to} 5 cm; blue dots - size > 5 cm); D) Nodal status (red dots - node negative; blue dots - node positive); E) Grade of the tumor (red dots - grade 1; blue dots - grade 2; green dots - grade 3). For each analysis the confusion matrix is also reported.
Supplementary figure S2 from Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population
Authors: Hart Christopher D. , Vignoli Alessia , Tenori Leonardo , Uy Gemma Leonora , Van To Ta , Adebamowo Clement , Hossain Syed Mozammel , Biganzoli Laura , Risi Emanuela , Love Richard R. , Luchinat Claudio , Di Leo Angelo
Published: April 2023

Spectral clustering by treatment centre, demonstrated by score plots of the first three components of unsupervised PCA using (A) the entire dataset, and (B) the reduced data-matrix (bins related to lactate removed). In these plots each dot represents a 1H NMR CPMG patient spectrum. The colors represent the sample provenance: red, Vietnam, Hanoi - Hospital K; orange, Philippines, Manila - PGH; yellow, Vietnam, Danang - Danang General; green, Philippines, Cebu - Vicente Sotto Hospital; cyan, Philippines, Manila - Santo Tomaso Hospital; turquoise, Philippines, Manila - Rizal; sky blue, Philippines, Manila - East Avenue; blue, Nigeria, Ibadan - University College Hospital; purple, Bangladesh, Dhaka - Dhaka Medical College; magenta, Bangladesh, Khulna - Khulna Medical College; pink, Bangladesh, Dhara - BSMMU.
Supplementary Figure Legend from Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population
Authors: Hart Christopher D. , Vignoli Alessia , Tenori Leonardo , Uy Gemma Leonora , Van To Ta , Adebamowo Clement , Hossain Syed Mozammel , Biganzoli Laura , Risi Emanuela , Love Richard R. , Luchinat Claudio , Di Leo Angelo
Published: April 2023

Supplementary Figure Legend
Table S4 from Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Authors: Fu Hangcheng , Zhu Yu , Wang Yiwei , Liu Zheng , Zhang Junyu , Xie Huyang , Fu Qiang , Dai Bo , Ye Dingwei , Xu Jiejie
Published: April 2023

Clinical Characteristics of Patients According to the Stromal Immunotype in the Training, Testing and Validation Cohorts
Suppl Figure legends from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Authors: Puhr Martin , Hoefer Julia , Eigentler Andrea , Ploner Christian , Handle Florian , Schaefer Georg , Kroon Jan , Leo Angela , Heidegger Isabel , Eder Iris , Culig Zoran , Van der Pluijm Gabri , Klocker Helmut
Published: April 2023

Suppl Figure legends